English

MAIO, 26
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PERFIL DOS PARTICIPANTES

Categorias de produtos

Branded generics: 48.3%
96.6

Biological products: 43.3%
86.6

Biosimilars: 26.7%
53.4

Hospital products: 40.0%
80

Innovative medicines: 58.7%
117.4

mais informações




Interesses estratégicos

In-licensing: 46.7%
93.4

Out-licensing: 40.0%
80

Co-marketing: 31.7%
63.4

Co-promotion: 26.7%
53.4

Co-development: 46.7%
93.4

mais informações




Área terapêutica

Cardiovascular: 40.0%
80

CNS: 45.0%
90

Infectious diseases: 35.0%
70

Pain: 41.7%
83.4

Respiratory: 33.3%
66.6

mais informações



PARTICIPANTES 2017

Allergy/immunology: 17.5%

Cardiovascular: 40.0%

CNS: 45.0%

Dentistry: 5.0%

Dermatology: 15.0%

Drug delivers technol.: 20.0%

Gastroenterology: 19.2%

Gerontology: 11.7%

Gynecology: 18.3%

Infectious diseases: 35.0%

Hematology: 17.4%

Ophthalmology: 13.3%

Oncology: 24.2%

Orthopedics: 15.0%

Pain: 41.7%

Pediatrics: 15.0%

Psychiatrics: 17.5%

Respiratory: 33.3%

Rheumatology: 19.2%

Urology: 15.8%

Vaccines: 9.2%

partner